After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Recursion Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Recursion Pharmaceuticals Inc is $2.53B. A total of 33.12 million shares were traded on the day, compared to an average of 39.97M shares.
In the most recent transaction, Gibson Christopher sold 40,000 shares of RXRX for 4.25 per share on Jan 05 ’26. After the transaction, the Director now owns 933,839 company shares. In a previous transaction on Jan 06 ’26, Borgeson Blake bought 220,000 shares at 4.36 per share.
Among the insiders who bought shares, Gibson Christopher acquired of 40,000 shares on Jan 05 ’26 at a per-share price of $4.25. In another insider transaction, Taylor Ben R sold 21,383 shares at $4.18 per share on Dec 29 ’25. Company shares held by the Chief Financial Officer now total 761,550.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RXRX has a high of $12.36 and a low of $3.79.
As of this writing, RXRX has an earnings estimate of -$0.32 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.21 per share and a lower estimate of -$0.46. The company reported an EPS of -$0.53 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RXRX’s latest balance sheet shows that the firm has $516.56M in Cash & Short Term Investments as of fiscal 2021. There were $11.48M in debt and $46.66M in liabilities at the time. Its Book Value Per Share was $2.13, while its Total Shareholder’s Equity was $542.94M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RXRX is Buy with a score of 3.56.
